GENEVA, Aug. 10 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development ZoneShijiazhuang, Hebei 050027), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2025/074698) for "ANTI-DLL3 ANTIBODY AND USE" on Jan 24, 2025. With publication no. WO/2025/162258, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Prop...